Optimization of potassium management in patients with chronic kidney disease and type 2 diabetes on finerenone

Author:

Ortiz Alberto1ORCID,Alcázar Arroyo Roberto2,Casado Escribano Pedro Pablo3,Fernández-Fernández Beatriz1,Martínez Debén Francisco4,Mediavilla Juan Diego5,Michan-Doña Alfredo6ORCID,Soler Maria Jose7,Gorriz Jose Luis8ORCID

Affiliation:

1. Nephrology and Hypertension Department, IIS-FJD and Hospital Universitario Fundación Jiménez Díaz, Madrid, Spain

2. Nephrology Department, Hospital Universitario Infanta Leonor, Madrid, Spain

3. Internal Medicine Department, Hospital Universitario de La Princesa, Madrid, Spain

4. Internal Medicine Department, Hospital Naval, Complexo Hospitalario Universitario de Ferrol. Departamento de Ciencias de la Salud. Universidad de La Coruña, Madrid, Spain

5. Internal Medicine Department, Instituto de Investigación Biosanitaria ibs, Hospital Universitario Virgen de las Nieves, Granada, Spain

6. Department of Medicine, Hospital Universitario de Jerez, Biomedical Research and Innovation Institute of Cadiz (INiBICA), Cádiz, Spain

7. Nephrology Department, Hospital Universitario Vall d‘Hebron, Barcelona, Spain

8. Nephrology Department, Hospital Clínico Universitario de Valencia, Universidad de Valencia, Valencia, Spain

Funder

Bayer Hispania

Instituto de Salud Carlos III

Publisher

Informa UK Limited

Subject

Pharmacology (medical),General Pharmacology, Toxicology and Pharmaceutics,General Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3